38° Rain

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.405 -0.055 (-1.59%)

Streaming Delayed Price Updated: 2:48 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

3 Healthcare Stocks Injecting AI for Big Gains ↗

July 13, 2024

Investors should keep a close eye on these AI healthcare stocks as they revolutionize the future of drug development and patient care.

Via InvestorPlace

Topics Artificial Intelligence

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street ↗

July 12, 2024

Are the analysts right about these Nvidia-backed AI stocks?

Via The Motley Fool

Topics Artificial Intelligence

Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same? ↗

July 10, 2024

SoundHound AI, Arm, Nano-X, Recursion, and TuSimple are all in Nvidia's portfolio.

Via The Motley Fool

Topics Artificial Intelligence

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs ↗

July 08, 2024

Longevity stocks are at the forefront of combating age-related illnesses with transformative AI-driven drug discovery.

Via InvestorPlace

Why SoundHound AI Stock Lost 22% Last Month ↗

July 08, 2024

Check out why SoundHound AI's stock dropped in June, despite a complete lack of negative news. Is this AI stock a great buy today?

Via The Motley Fool

Topics Artificial Intelligence

3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030 ↗

July 03, 2024

These high-risk, high-reward stocks have the potential to turn $1K into $1M by 2030, according to Amazon-backed AI Claude 3.5 Sonnet.

Via InvestorPlace

Topics Artificial Intelligence

Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗

July 02, 2024

Via Benzinga

Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor ↗

July 01, 2024

Via Benzinga

Topics Artificial Intelligence

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet ↗

June 28, 2024

Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.

Via InvestorPlace

Why Recursion Pharmaceuticals Stock Is Tumbling Thursday ↗

June 27, 2024

Recursion announced that it intends to offer and sell 30,769,230 shares of its common stock for $6.50 per share in an underwritten public offering. The clinical-stage biotech company also said it plans...

Via Benzinga

Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 27, 2024

Via Benzinga

3 AI Stocks on the Edge of a Massive Surge ↗

June 27, 2024

Writers covering the AI stocks space agree on one thing: Nvidia’s dramatic rise is spawning a whole new wave of AI winners.

Via InvestorPlace

Topics Artificial Intelligence

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 27, 2024

Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning!

Via InvestorPlace

Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock

June 26, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On? ↗

June 26, 2024

After the market close on Wednesday, Recursion said it intends to offer and sell $200 million worth of its common stock in an underwritten public offering. All of the shares are being offered by...

Via Benzinga

Recursion Announces Proposed Offering of Class A Common Stock

June 26, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

June 26, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 25, 2024

Via Benzinga

Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? ↗

June 25, 2024

Shares of clinical stage biotech company Recursion Pharmaceuticals Inc (NASDAQ:RXRX) are trading higher Tuesday. The company's CEO Chris Gibson joined CNBC for an interview ahead of a presentation with...

Via Benzinga

What's Going On With Recursion Pharmaceuticals Stock Monday? ↗

June 24, 2024

Recursion Pharmaceuticals shares traded higher Monday after the company provided updated guidance and partnership updates at its Investor Day. The stock is continuing to move higher after hours amid a...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 24, 2024

Via Benzinga

Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day

June 24, 2024

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Largest Clinical-Stage BioTech Drug Stocks Declined 6% ↗

June 22, 2024

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...

Via Talk Markets

NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

June 18, 2024

Via Benzinga

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th ↗

June 17, 2024

The global

Via Talk Markets

3 Stocks Under $10 Set to Quadruple by 2025: June Edition ↗

June 13, 2024

Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.

Via InvestorPlace

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week ↗

June 10, 2024

The global

Via Talk Markets

Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim ↗

June 07, 2024

The CEO has set a high bar for the business, and if it hits it, the stock could easily 10x in value.

Via The Motley Fool

Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance ↗

June 05, 2024

These Nvidia partner stocks stand to gain from the semiconductor's industry dominance, but they have plenty of upside of their own.

Via InvestorPlace

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

Sections

Services